[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353484-105":59,"doc-detail-353484-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-tumour-derived-organoid-biobank-maps-cancer-gene-dependencies","A tumour-derived organoid biobank maps cancer gene dependencies","","Cancer cell lines remain foundational for research and drug discovery but incompletely represent tumour diversity, lack linked patient context, and undergo culture adaptation. Tumour organoids provide renewable, genetically stable 3D models derived from patient tissue. This study generated and characterized 256 clinically annotated colorectal, oesophageal, ovarian, pancreatic and gastric tumour organoids and performed whole-genome and transcriptome sequencing. Genome-wide CRISPR–Cas9 screens across 162 organoids mapped gene dependencies and revealed markers, organoid-specific essential genes, and evolution-driven vulnerabilities from paired pre- and post-treatment samples.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-tumour-derived-organoid-biobank-maps-cancer-gene-dependencies/353484/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-tumour-derived-organoid-biobank-maps-cancer-gene-dependencies/353484.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem do the researchers address with existing cancer models?","Question",{"text":113,"@type":114},"Cancer cell lines are foundational but incompletely capture tumour diversity, lack linked patient context, and adapt to culture. The study addresses these limitations by using patient-derived tumour organoids.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many tumour organoids were generated and what cancers were included?",{"text":118,"@type":114},"The work derived and characterized 256 clinically annotated tumour organoids from colorectal, oesophageal, ovarian, pancreatic, and gastric cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental approach mapped gene dependencies?",{"text":122,"@type":114},"Genome-wide CRISPR–Cas9 screens were performed across 162 organoids, supported by whole-genome and transcriptome sequencing and integrative analyses.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353484,1790557423,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \n\n| A tumour-derived organoid biobank maps cancer gene dependencies |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-026-10830-y](https://doi.org/10.1038/s41586-026-10830-y)\u003Cbr>Received: 6 February 2025 Accepted: 19 June 2026 Published online: 5 August 2026 Open access\u003Cbr> Check for updates | C. Herranz-Ors1, S. G. Bhosle1, A. E. Beck1, J. G. R. Gilbert1, G. Picco1, J. Espejo Valle-Inclan2, F. Muyas2, S. Valentini1, A. E. Andres1, R. Ansari1, S. Barthorpe1, G. Battarbee1, C. M. Beaver1,\u003Cbr>S. Brocklesby1, J. Cantwell1, C. A. Collins1, J. Davis1, H. G. Dimitrova1, J. Doran1, E. Efendi1,\u003Cbr>K. Evans1, M. Fekry1, T. A. Fowler1, M. Garcia-Casado1, J. A. T. Griffiths1,3, C. Hall1, R. Hamer1, C. Hardy1, Z. Hewitson1, E. Hitch1, L. Holland1, D. A. Jackson1, N. Joshi1, A. Kavasakali1,\u003Cbr>L. Letchford1,42, H. B. Lightfoot1, H. Lingala1, I. Mali1, K. May1, T. Mironenko1, J. Morris1,\u003Cbr>C. Pacini1, S. Price1, G. Robert-Tissot1, H. A. Rogers1, J. V. Smith1, K. Smith1, E. Souster1,4, W. J. Spence1, F. Thomas1, S. F. Vieira1,42, S. Walker1, G. Alfonsin1,5, H. Bermingham6, H. Coles7,\u003Cbr>D. P. Ennis8, A. Freeman7, G. Giannone8, N. Grehan7, E. A. Griffiths6,9, J. Hall3, S. L. Lee10,\u003Cbr>E. Y. L. Leung6,11, C. Loreno7, C. Millington7, A. Mirnezami10, B. Nutzinger7, K. Orzechowska11, C. M. A. Pinna11, A. M. Redmond7, K. Roberts6,9, S. Roy10,12, D. A. Sanders3, P. Taniere6, M. Vias3, K. Wanigasooriya6,13, OCCAMS Consortium*, M. R. Stratton1, L. M. Staudt14, U. McDermott1,4, J. D. Brenton3, I. A. McNeish8, A. Biankin15, O. J. Sansom15,16, I. Cortes-Ciriano1,2,\u003Cbr>T. J. Underwood10, R. C. Fitzgerald7, A. D. Beggs6,11, H. E. Francies1,43 & M. J. Garnett1 ✉\u003Cbr>Cancer cell lines remain foundational for research and drug discovery, yet they incompletely capture tumour diversity, lack linked patient context, and have undergone adaptation to culture. Tumour organoids are three-dimensional cultures derived from patient tissue that offera powerful complement to cell lines1. Here we derived and characterized 256 clinically annotated tumour organoids directly from colorectal, oesophageal, ovarian, pancreatic and gastric cancers as renewable, genetically stable models. Extensive characterization of each model and matched patient tumour samples included whole-genome and transcriptome sequencing, and genome-wide CRISPR–Cas9 screens across 162 organoids mapped gene dependencies. Integrative analyses revealed genomic and clinical markers of dependency across common and rare subtypes, identified organoid-specific essential genes, and revealed targetable vulnerabilities following tumour evolution in paired pre-and post-treatment samples. In colorectal cancer, functional and pharmacological interrogation of theEGFR–RAS–MAPK axis uncovered differential effects ofKRAS variant alleles. This open, publicly available resource provides a systematic map of gene dependencies inpatient-derived organoids, expanding the model diversity and mechanistic insight needed to advance precision oncology. |  |\n| The multi-omics characterization of hundreds of 2D cancer cell lines |  | Furthermore, most cell lines adapt to in vitro culture in ways that are |\n| and their perturbation in pharmacological and genetic screens2–9 has |  | not well understood, and reference patient-matched tumour samples |\n| been used to build reference maps of cancer dependencies to inform |  | are unavailable for comparisons, collectively hampering their use for |\n| precision cancer medicines. However, the widely available set of |  | pre-clinical research and discovery. Patient-derived xenograft mod- |\n| around 1,000 human cancer cell lines9 has limitations, including biased |  | els capture elements of the tumour microenvironment, but require |\n| representation of certain cancer subtypes or absence of others, no |  | specialized facilities and substantial resources, limiting broader use. |\n| patient-matched germline genetic data for accurately calling somatic |  | Tumour organoids are ","cbCaioE0evzPbCvk","https://ap.wps.com/l/cbCaioE0evzPbCvk","pdf",23205283,"English","# Background\n# Organoid biobank generation and characterization\n## Multi-omics profiling\n## CRISPR–Cas9 screening\n# Integrative dependency mapping\n## Clinical and genomic markers\n## Essential genes and evolution-informed vulnerabilities\n# Colorectal EGFR–RAS–MAPK pathway findings\n# Open resource for precision oncology","[{\"question\":\"What problem do the researchers address with existing cancer models?\",\"answer\":\"Cancer cell lines are foundational but incompletely capture tumour diversity, lack linked patient context, and adapt to culture. The study addresses these limitations by using patient-derived tumour organoids.\"},{\"question\":\"How many tumour organoids were generated and what cancers were included?\",\"answer\":\"The work derived and characterized 256 clinically annotated tumour organoids from colorectal, oesophageal, ovarian, pancreatic, and gastric cancers.\"},{\"question\":\"What experimental approach mapped gene dependencies?\",\"answer\":\"Genome-wide CRISPR–Cas9 screens were performed across 162 organoids, supported by whole-genome and transcriptome sequencing and integrative analyses.\"}]","A tumour-derived organoid biobank maps cancer gene dependencies | PDF",1790105668,76,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/898bf0b58fe280d3d536cf1d113c747d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8a8e58eddab4813ecf4bc1d523d4fa1.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e09bf3c30b2a868c43ef0e5fcd944bc4.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3499038458fb8927facfd757cac7d8bd.webp",980,1301]